Cranbury, NJ, United States of America

Ketan Mehta

USPTO Granted Patents = 31 


 

Average Co-Inventor Count = 2.3

ph-index = 27

Forward Citations = 1,684(Granted Patents)


Location History:

  • Princeton, NJ (US) (2015 - 2017)
  • Cranbury, NJ (US) (2011 - 2021)
  • Miami, FL (US) (2018 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Ketan Mehta: Pioneering the Future of Extended Release Amphetamine Innovations

Introduction:

Inventor Ketan Mehta, based in Cranbury, NJ, is a visionary who has dedicated his career to pushing the boundaries of technology and driving positive change through innovation. With a strong commitment to creativity, Mehta has solidified his reputation as a trailblazing inventor whose work continues to inspire the next generation of innovators.

Latest Patents:

Mehta's latest patents showcase his expertise in developing extended release amphetamine formulations that have the potential to revolutionize the pharmaceutical industry. His inventions include oral amphetamine extended release solid dose and liquid suspension compositions. These compositions utilize a combination of uncoated amphetamine-cation exchange resin complexes, barrier-coated amphetamine-cation exchange resin complex-matrix, and uncomplexed amphetamine, providing a therapeutically effective amount of amphetamine over an extended period, with a minimum thirteen-hour effect post-dose.

Career Highlights:

Mehta has accumulated an impressive portfolio of 30 patents, demonstrating his relentless pursuit of innovation and dedication to advancing the field of pharmaceuticals. As an inventor at Tris Pharma, Inc., Mehta has played a pivotal role in developing cutting-edge drug delivery technologies that have the potential to significantly improve patient outcomes.

Collaborations:

Mehta has had the privilege of collaborating with esteemed colleagues such as Yu-Hsing Tu and Ashok Perumal, whose expertise has complemented his own innovative approach. Together, they have worked towards transforming ideas into tangible solutions that have the power to make a meaningful impact in the healthcare industry.

Conclusion:

In conclusion, Ketan Mehta's innovative spirit and commitment to excellence have cemented his position as a leading inventor in the field of extended release amphetamine formulations. His work serves as a shining example of the transformative power of creativity and dedication in driving positive change, and his legacy will continue to inspire generations of innovators to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…